BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22311150)

  • 1. High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.
    Erpolat OP; Gocun PU; Akmansu M; Karakus E; Akyol G
    Strahlenther Onkol; 2012 Mar; 188(3):248-54. PubMed ID: 22311150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B.
    Qi G; Kudo Y; Ando T; Tsunematsu T; Shimizu N; Siriwardena SB; Yoshida M; Keikhaee MR; Ogawa I; Takata T
    Oral Oncol; 2010 Apr; 46(4):263-70. PubMed ID: 20138567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients.
    Vischioni B; Oudejans JJ; Vos W; Rodriguez JA; Giaccone G
    Mol Cancer Ther; 2006 Nov; 5(11):2905-13. PubMed ID: 17121938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of nuclear survivin expression in resected adenoid cystic carcinoma of the head and neck.
    Ko YH; Roh SY; Won HS; Jeon EK; Hong SH; Lee MA; Kang JH; Hong YS; Kim MS; Jung CK
    Head Neck Oncol; 2010 Oct; 2():30. PubMed ID: 21034499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neck.
    Hoellein A; Pickhard A; von Keitz F; Schoeffmann S; Piontek G; Rudelius M; Baumgart A; Wagenpfeil S; Peschel C; Dechow T; Bier H; Keller U
    Oncotarget; 2011 Aug; 2(8):599-609. PubMed ID: 21865609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of HuR, COX-2, and survivin in lung cancers; cytoplasmic HuR stabilizes cyclooxygenase-2 in squamous cell carcinomas.
    Kim GY; Lim SJ; Kim YW
    Mod Pathol; 2011 Oct; 24(10):1336-47. PubMed ID: 21572400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma.
    Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Masumori N; Sato N; Tsukamoto T
    Virchows Arch; 2013 Jan; 462(1):101-7. PubMed ID: 23179762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck.
    Pickhard A; Gröber S; Haug AK; Piontek G; Wirth M; Straßen U; Rudelius M; Reiter R
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):733-42. PubMed ID: 24726415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects and expression of Survivin and Aurora-b in laryngeal carcinoma].
    Hu CH; Wang WH; Wang Q; He XS
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 May; 31(10):737-743. PubMed ID: 29771033
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional characterization of novel mutations affecting survivin (BIRC5)-mediated therapy resistance in head and neck cancer patients.
    Knauer SK; Unruhe B; Karczewski S; Hecht R; Fetz V; Bier C; Friedl S; Wollenberg B; Pries R; Habtemichael N; Heinrich UR; Stauber RH
    Hum Mutat; 2013 Feb; 34(2):395-404. PubMed ID: 23161837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of survivin in pancreatic endocrine tumors.
    Ekeblad S; Lejonklou MH; Stålberg P; Skogseid B
    World J Surg; 2012 Jun; 36(6):1411-8. PubMed ID: 22089920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients.
    Farnebo L; Tiefenböck K; Ansell A; Thunell LK; Garvin S; Roberg K
    Int J Cancer; 2013 Oct; 133(8):1994-2003. PubMed ID: 23564498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma.
    Grabowski P; Kühnel T; Mühr-Wilkenshoff F; Heine B; Stein H; Höpfner M; Germer CT; Scherübl H
    Br J Cancer; 2003 Jan; 88(1):115-9. PubMed ID: 12556969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: correlation with clinicopathologic features and patient survival.
    Shen YC; Hu FC; Jeng YM; Chang YT; Lin ZZ; Chang MC; Hsu C; Cheng AL
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):417-23. PubMed ID: 19190145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma.
    Sun PL; Jin Y; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
    Virchows Arch; 2013 Sep; 463(3):427-36. PubMed ID: 23907568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurora B expression as a prognostic indicator and possible therapeutic target in oral squamous cell carcinoma.
    Pannone G; Hindi SA; Santoro A; Sanguedolce F; Rubini C; Cincione RI; De Maria S; Tortorella S; Rocchetti R; Cagiano S; Pedicillo C; Serpico R; Lo Muzio L; Bufo P
    Int J Immunopathol Pharmacol; 2011; 24(1):79-88. PubMed ID: 21496390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear survivin expression correlates with endoglin-assessed microvascularisation in laryngeal carcinoma.
    Marioni G; Ottaviano G; Marchese-Ragona R; Fasanaro E; Tealdo G; Zanotti C; Randon B; Giacomelli L; Stellini E; Blandamura S
    J Clin Pathol; 2017 Dec; 70(12):1033-1037. PubMed ID: 28446541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical Study of Mitosis-regulatory Proteins in Gastroenteropancreatic Neuroendocrine Neoplasms.
    Briest F; Wang Y; Arsenic R; Elezkurtaj S; Berg E; Greshake S; Lock AC; Hörsch D; Arnold CN; Hummel M; Siegmund B; Grabowski P
    Anticancer Res; 2018 Jul; 38(7):3863-3870. PubMed ID: 29970506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between survivin and aurora-B kinase plays an important role in survivin-mediated up-regulation of human telomerase reverse transcriptase expression.
    Furuya M; Tsuji N; Kobayashi D; Watanabe N
    Int J Oncol; 2009 Apr; 34(4):1061-8. PubMed ID: 19287963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B.
    Tarnawski A; Pai R; Chiou SK; Chai J; Chu EC
    Biochem Biophys Res Commun; 2005 Aug; 334(1):207-12. PubMed ID: 15993841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.